Phone check-ins to manage side effects and support hormone therapy
Treatments studied
Part of Cancer clinical trials.
This study tests a telehealth program to help people taking hormone therapy after breast cancer treatment manage side effects and stick with their medication. It may help you feel better and stay on your treatment plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 21 or older.
- You have early-stage breast cancer (stages 0 to 3B) that is hormone receptor positive (ER+/PR+).
- You have finished your primary treatment (surgery, chemotherapy, or radiation).
- You started taking hormone therapy pills within the last 3 to 12 months.
- You are able to read and respond in English or Spanish.
- You are feeling some distress (at least 4 on a 0-10 scale) about your hormone therapy side effects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
This trial tests if tracking how you feel and reporting your symptoms can help women with hormone receptor-positive breast cancer take their hormone-blocking medication more consistently. It may be a good fit if you have been prescribed aromatase inhibitors or similar therapy and have had trouble taking it as directed.
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
This study tests a texting program to help women in Rwanda stay consistent with their daily hormone therapy for breast cancer. The goal is to support you in taking your pill regularly and improve your long-term health.
Hear when a new Hormone-receptor-positive Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.